Work

Low Relapse Rate in Younger Patients ≤ 60 Years Old with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML) Treated with Crenolanib and Cytarabine/Anthracycline Chemotherapy

Year: 2017

Type: article

Source: Blood

DOI: 10.1182/blood.v130.suppl_1.566.566

Authors: Eunice S. Wang, Martin S. Tallman, Richard M. Stone, Roland B. Walter, Chatchada Karanes, Vinay Jain, Robert H. Collins

Institutions: Roswell Park Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, Fred Hutch Cancer Center, City Of Hope National Medical Center, City of Hope, Arog Pharmaceuticals (United States), The University of Texas Southwestern Medical Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2953509522

FWCI: 5.248

Cites:

Cited by: 38

Related to: 20